StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.90+0.08 (+9.83%)

Close on Nov 18, 2026Market cap $104.20MP/E –Yield –

NovaBridge Biosciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

NovaBridge Biosciences's operating cash flow for the twelve months ending Dec 31, 2020 was CN¥433.56M. For fiscal 2023 it was -CN¥1.30B. The highest annual figure on record is CN¥433.56M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2023Dec 31, 2023-CN¥1.30B–
FY2022Dec 31, 2022-CN¥1.10B–
FY2021Dec 31, 2021-CN¥973.09M-324.4%
FY2020Dec 31, 2020CN¥433.56M–
FY2019Dec 31, 2019-CN¥867.98M–
FY2018Dec 31, 2018-CN¥280.71M–
FY2017Dec 31, 2017-CN¥252.16M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2020Dec 31, 2020CN¥1.02B–
Q4 FY2019Dec 31, 2019-CN¥215.99M–

More NovaBridge Biosciences figures

See a number that looks wrong?